Pancreatic Cancer Research

ResearcherAbramson Cancer CenterActive in the last 2 years

Andrew Haas

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110258522. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2014: 1 trial · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 1

  1. Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2025.102301↗

Trials 1

  1. CART-meso in Mesothelin Expressing Cancers Principal investigator NCT02159716↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew J. Rech · 1 shared paper, 2025 · strength 0.17
  2. Joseph A. Fraietta · 1 shared paper, 2025 · strength 0.17
  3. Janos Laszlo Tanyi · 1 shared paper, 2025 · strength 0.17
  4. Maria Angela Aznar · 1 shared paper, 2025 · strength 0.17
  5. Hua Huang · 1 shared paper, 2025 · strength 0.17
  6. Carl H. June · 1 shared paper, 2025 · strength 0.17
  7. Don L. Siegel · 1 shared paper, 2025 · strength 0.17
  8. Gabriela Plesa · 1 shared paper, 2025 · strength 0.17
  9. Mark H. O’Hara · 1 shared paper, 2025 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.